Table 3 |
||||||
|
Haematological Characteristics of Patients on Day 0, 7 and 28 |
||||||
| Treatment Group 1 (≥30 kg) |
Treatment Group 2(15–29 kg) |
|||||
|
|
||||||
| D0 |
D7 |
D28 |
D0 |
D7 |
D28 |
|
|
|
||||||
| Hb (mg/L) |
||||||
| Male |
11.67 ± 4.12 |
11.15 ± 2.37 |
12.19 ± 2.40 |
10.70 ± 2.65 |
9.53 ± 2.19 |
11.56 ± 1.34 |
| Female |
11.47 ± 2.49 |
10.27 ± 1.93 |
11.45 ± 1.42 |
10.84 ± 2.99 |
9.07 ± 3.20 |
11.58 ± 1.35 |
| ESR |
23.79 ± 26.74 |
14.34 ± 17.23 |
11.82 ± 14.96 |
42.73 ± 29.16 |
18.17 ± 23.66 |
11.53 ± 13.52 |
| TWBC (× 109/L) |
5.27 ± 1.87 |
5.35 ± 1.93 |
5.15 ± 1.54 |
7.25 ± 1.11 |
5.91 ± 2.50 |
5.79 ± 4.85 |
| Lymphocytes (× 109/L) |
2.22 ± 1.05 |
2.59 ± 1.09 |
2.66 ± 1.11 |
2.87 ± 3.34 |
2.97 ± 1.69 |
3.14 ± 3.08 |
| Neutrophils (× 109/L) |
2.69 ± 1.28 |
2.55 ± 1.10 |
2.33 ± 0.80 |
4.10 ± 8.01 |
2.67 ± 1.21 |
2.47 ± 1.86 |
| Monocytes (× 109/L) |
0.24 ± 0.16 |
0.09 ± 0.08 |
0.08 ± 0.08 |
0.09 ± 0.11 |
0.08 ± 0.08 |
0.08 ± 0.96 |
| Eosinophils (× 109/L) |
0.12 ± 0.14 |
0.15 ± 0.15 |
0.09 ± 0.11 |
0.08 ± 0.11 |
0.15 ± 0.22 |
0.10 ± 0.11 |
|
|
||||||
|
Agomo et al. Malaria Journal 2008 7:172 doi:10.1186/1475-2875-7-172 |
||||||
